Agitation
90
9
10
52
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
19 trials with published results (21%)
Research Maturity
52 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
6 terminated out of 90 trials
89.7%
+3.1% vs benchmark
39%
35 trials in Phase 3/4
37%
19 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (90)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Acupressure for Agitation, Pain, and Sleep in Mechanically Ventilated ICU Patients
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial)
PARO-agitation-study
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Neurosteer Bedside Monitoring System
Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Nabilone for Agitation Blinded Intervention Trial
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
Doll Therapy for Agitated Elderly Dementia People
Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery